louisakewell, Author at European Medical Journal - Page 129 of 153

EMJ

Adjuvant chemotherapy use in breast cancer after introducing the Oncotype DX® Breast Cancer Assay

The Oncotype DX® Breast Cancer Assay, a multigene assay, stratifies breast cancer patients into groups that are at low, intermediate or high risk for…

EMJ

Type 1 Diabetes Stunts Brain Growth

CHILDREN with Type 1 diabetes (T1D) have shown slower brain growth than children without the disease. Frequent exposure to hyperglycaemia afflicting…

EMJ

Nature and Nurture Come Together to Trigger Diabetes

THE EPIGENOME has been revealed to play a significant role in diabetes onset, providing clues into how genes and the environment interact…

EMJ

AbbVie’s VIEKIRAX® (Ombitasvir/Paritaprevir/Ritonavir) and EXVIERA ® (Dasabuvir) Licensed for Use in the UK for the Treatment of Chronic Hepatitis C

MAIDENHEAD, UK, Jan. 19, 2015 – AbbVie’s all-oral, short course (12 weeks for the majority of patients), interferon-free treatments VIEKIRAX®…

EMJ

New Stats Reveal Almost Half of the UK Are Unaware of Crucial Link between Diet and Cancer Development

Surprising new statistics reveal that 41% of the British population are oblivious to the role that diet plays in the development of cancer…

EMJ

Targeting Monocytes to Help Treat Autoimmune Disorders?

SUPPRESSION of the immune system in fighting diseases could be the fault of a population of white blood cells (WBCs), a group of studies led by…

EMJ

Monitoring ADMA Levels the Key to Avoiding Cardiovascular Disease?

FEARFUL side-effects that have prohibited the appearance of certain anti-inflammatory arthritis drugs in our pharmacies could soon become irrelevant…

EMJ

Quick Imaging Unlocks Path to Valvular Heart Disease Treatment

ACCURACY of the physical diagnoses of heart conditions is boosted through the use of a handheld ultrasound device, with more successful diagnoses of…

EMJ

Key to Heart Attack Treatment May Come from Within

INTRACORONARY injection of a patient’s own bone marrow (BM) cells could emerge as the ultimate treatment for heart attacks.

EMJ

Basilea Announces That FDA’s Anti-Infective Drugs Advisory Committee Recommends Approval of Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis

Basel, Switzerland, January 22, 2015 – Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced that the U.S. Food and Drug Administration’s (FDA)…